Skip to content

Reversal of temperature responses to methylone mediated through bi-directional fecal microbiota transplantation between hyperthermic tolerant and naïve rats.

Robert Goldsmith, Amal Aburahma, Sudhan Pachhain, Sayantan Roy Choudhury, Vipa Phuntumart, Ray A. Larsen, Christopher S Ward, Jon E. Sprague

Temperature 2022 DOI: 10.1080/23328940.2022.2069965 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Controlled animal experiment Peer reviewed
Population Male rats, including methylone-induced hyperthermic tolerant (MHT) and methylone-naïve (MN) groups
Interventions Methylone Fecal Microbiota Transplantation (FMT)
Duration Methylone once per week until tolerance by the fourth week; daily FMT for seven days prior to the next methylone treatment
Keywords Fmt Methylone Ucp Hyperthermia Temperature Tolerance
Key findings Fecal microbiota transplantation from methylone-tolerant rats reversed tolerance in tolerant recipients, and transplantation from tolerant donors induced tolerance in drug-naïve recipients on their first methylone exposure. These phenotypic changes were accompanied by altered norepinephrine, UCP1, UCP3, and TGR5 expression and shifts in gut bacterial abundance, suggesting the microbiome may contribute to sympathomimetic-mediated hyperthermia.

Abstract

The synthetic cathinone ("bath salt") methylone induces a hyperthermia response and with chronic administration tolerance to this hyperthermia has been reported. The microbiome-gut-brain axis has been implicated in multiple bodily systems and pathologies, and intentional manipulation of the gut-microbiome has yielded clinically significant results. Here, we examined the effects of bi-directional Fecal Microbiota Transplantation (FMT) between methylone-induced hyperthermic tolerant (MHT) and methylone-naïve (MN) rats. Rats treated with methylone once per week developed tolerance to methylone-induced hyperthermia by the fourth week. Once tolerant, daily bi-directional FMT between the two groups were performed for seven days prior to the next methylone treatment. The FMT abated the developed tolerance in the MHT group. When treated with methylone for the first time following FMT, recipient MN rats displayed significant tolerance to hyperthermia despite it being their initial drug treatment. Post-FMT, MHT rats displayed elevations in norepinephrine and expression of UCP1, UCP3 and TGR5 in brown adipose tissue, with reductions in expression of TGR5 and UCP3 in skeletal muscle. The pre- and post-FMT methylone tolerance phenotypes of transplant recipients are concurrent with changes in the relative abundance of several classes of Proteobacteria, most evident for Gammaproteobacteria and Alphaproteobacteria. MHT recipients demonstrated a marked increase in the relative proportion of the Firmicutes class Erysipelotrichia. These findings suggest that transplantation of gut-microbiomes can confer phenotypic responses to a drug and that the microbiome may be playing a major role in sympathomimetic-mediated hyperthermia. Abbreviations: 3,4-methylenedioxymethamphetamine (MDMA); methylone-induced hyperthermic tolerant (MHT); methylone-naïve (MN); fecal microbiota transplantation (FMT); uncoupling protein (UCP); subcutaneous (sc); intraperitoneal (ip); brown adipose tissue (BAT); skeletal muscle (SKM); sympathetic nervous system (SNS); norepinephrine (NE); quantitative PCR (qRT-PCR); quantification cycle (Cq); High Performance Liquid Chromatography-Electrochemical Detection (HPLC-EC); amplicon sequence variants (ASVs); principal coordinates analysis (PCoA); permutational multivariate analysis (PERMANOVA).

Citations in the library

Explore topics